Kellner Capital’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Kellner Capital’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-65,697	Closed	-$3.61M	–	53
2022 Q2	$3.61M	Buy	+65,697	New	+$3.45M	2.44%	13

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Kellner Capital's SRRA Position: Q3 2022 in Review

Kellner Capital sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 65,697 shares — an estimated $3.61M sold.

Kellner Capital first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $3.61M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

Kellner Capital reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Kellner Capital sold 65,697 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $3.61M.
Kellner Capital first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Kellner Capital's Sierra Oncology, Inc. Common Stock position peaked at $3.61M in Q2 2022.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Kellner Capital's 13F filing for Q3 2022, filed 14 Nov 2022.